Estimation of creatinine clearance in morbidly obese patients

American Journal of Health-System Pharmacy

Volumn 66, Issue 7, 2009, Pages 642-648

  Demirovic, Jasmina A ^a   Pai, Amy Barton ^b   Pai, Manjunath P ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

Calculations; Creatinine; Methodology; Obesity; Weight

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALCULATION; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL;

EID: 63449109827     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080200     Document Type: Article

References (26)

1. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295:1549-55.
2. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series no. 85 4. http://whqlibdoc.who.int/trs/ WHO-TRS-854.pdf (accessed 2008 Dec 22).
3. Eknoyan G. Obesity, diabetes, and chronic kidney disease. Curr Diab Rep. 2007; 7:449-53.
4. Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000; 278:F817-22.
5. Spruill WJ, Wade WE, Cobb HH 3rd. Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy. Am J Health-Syst Pharm. 2007; 64:652-60.
6. Salazar DE, Corcoran GB. Predicting
7. creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988; 84:1053-60.
8. Dionne RE, Bauer LA, Gibson GA et al. Estimating creatinine clearance in morbidly obese patients. Am J Hosp Pharm. 1981; 38:841-4.
9. Leader WG, Tsubaki Y, Chandler MH. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients. Am J Hosp Pharm. 1994; 51:2125-30.
10. Snider DR, Kruse JA, Bander JJ et al. Accuracy of estimated creatinine clearance in obese pal ients with stable renal function in the intensive care unit. Pharmacotherapy. 1995; 15:747-53.
11. Spinier SA, Nawarskas JJ, Boyce EG et al. Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Ann Pharmacother. 1998; 32:1275-83.
12. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;
13. 11:A0828. Abstract.
14. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004; 58:1 19-33.
15. Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
16. Pai MP, Paloucek FP. The origin of the "ideal" body weight equations. Ann Pharmacother. 2000; 34:1066-9.
17. Sawyer WT, Canaday BR, Poe TE et al. Variables affecting creatinine clearance prediction. Am J Hosp Pharm. 1983; 40:2175-80.
18. Han PY, Duffull SB, Kirkpatrick CM et al. Dosing in obesity: a simple solution to a big problem. Chn Pharmacol Ther. 2007; 82:505-8.
19. Janmahasatian S, Duffull SB, Ash S et al. Quantification of lean bodyweight. Clin Pharmacol met. 2005; 44:1051-65.
20. Tanganelli E, Prencipe L, Bassi D et al. Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase. Chn Chem. 1982;28:1461-4.
21. American Society for Clinical Nutrition. Bioelectric impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am J Clin Nutr. 1996; 64(suppl):524S-532S.
22. Gray DS, Bray GA, Gemayel N et al. Effect of obesity on bioelectrical impedance. Am J Chn Nutr. 1989; 50:255-60.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Appendix 3: methodological aspects of evaluating equations to predict GFR and calculations using 24-hour urine samples,www.kidney.org/professionals/KDOQI/ guidelines-ckd/ pl0-appendix3.htm (accessed 2008 Jul 2).
24. Duffull SB, Dooley MJ, Green B et al. A standard weight descriptor for dose adjustment in the obese patient. Chn Pharmacokinet. 2004; 43:1167-78.
25. Janmahasatian S, Duffull SB, Chagnac A et al. Lean body mass normalizes the effect of obesity on renal function. Br J Chn Pharmacol. 2008; 65:964-5.
26. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6-28.